The 5 analysts offering 12-month price forecasts for Catalyst Biosciences Inc have a median target of 16.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +269.52% increase from the last price of 4.33.
The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Biosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.66
Reporting Date Aug 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.